The above-mentioned guideline by Rosenzweig JL, Ferrannini E, Grundy SM, Haffner SM, Heine RJ, Horton ES, and Kawamori R (J Clin Endo Metab. 2008;93(10): 3671–3689; doi: 10.1210/jc.2008-0222) was retired and replaced by the following publication: Rosenzweig JL, Bakris GL, Berglund LF, Hivert M-F, Horton ES, Kalyani RR, Murad MH, Vergès BL. Primary Prevention of ASCVD and T2DM in Patients at Metabolic Risk: An Endocrine Society Clinical Practice Guideline. J Clin Endo Metab. 2019;104(9): 3939–3985; doi: 10.1210/jc.2019-01338 doi: 10.1210/jc.2008-0222.
ASJC Scopus subject areas
- Endocrinology, Diabetes and Metabolism
- Clinical Biochemistry
- Biochemistry, medical